NCT03300102View on ClinicalTrials.gov

Acceptability and Feasibility Study of Patient-specific 'Tumouroids' as Personalised Treatment Screening Tools

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

August 1, 2018

Study Completion Date

December 31, 2018

Conditions
Cancer
Interventions
OTHER

Questionnaires, interviews and or tissue donation

Subjects will be asked to complete either structured questionnaires, semi-structured interviews or donate tissue. There will be some overlap, but each subject does not have to do all three interventions.

Trial Locations (2)

NW12BX

Surgical & Interventional Trials Unit, London

NW3 2QG

Royal Free Hospital, London

All Listed Sponsors
lead

University College, London

OTHER

NCT03300102 - Acceptability and Feasibility Study of Patient-specific 'Tumouroids' as Personalised Treatment Screening Tools | Biotech Hunter | Biotech Hunter